Roche and Genentech (NYSE: DNA) signed a merger agreement under which Roche will acquire the outstanding publicly held interest in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE